Therapeutic effect of a newly developed antioxidative agent (OPC-15161) on experimental immune complex nephritis.
The effect of a newly developed free radical scavenger (OPC-15161) on the progression of nephrotoxic serum (NTS) nephritis was evaluated. NTS nephritis rats were sacrificed immediately before and 1, 2, 3, 6, and 24 h and 13 and 19 days after intravenous injection of NTS. The tissue content of phosphatidylcholine hydroperoxide, the activity of superoxide, the activity of superoxide dismutase in the renal cortex, and the serum malondialdehyde levels were measured. The phosphatidylcholine hydroperoxide content in the renal cortex of OPC-15161-treated NTS nephritis rats was lower than that in the control rats 24 h after NTS injection. The activity of superoxide dismutase in OPC-15161-treated rats was sustained in contrast to the decrease in this activity in the control rats 6 h after injection of NTS. The effects of OPC-15161, dipyridamole, and prednisolone on NTS nephritis rats were investigated. OPC-15161 (20 mg/kg p.o.) showed a potent inhibitory effect on the urinary protein excretion, whereas dipyridamole (30 and 100 mg/kg p.o.) and prednisolone (2 mg/kg p.o.) had less suppressive effects. In view of these results, we conclude that OPC-15161 notably ameliorated the urinary protein excretion by way of the suppression of lipid peroxidation in the renal tissue of NTS nephritis rats.
Sanaka
T
T
Kidney Center, Department of Internal Medicine, Tokyo Women's Medical College, Shinjuku-ku, Japan.
Nakano
Y
Y
Nishimura
H
H
Shinobe
M
M
Higuchi
C
C
Omata
M
M
Nihei
H
H
Sugino
N
N
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D004176:Dipyridamole / Q000627:therapeutic use; D016166:Free Radical Scavengers / Q000627:therapeutic use; D007105:Immune Complex Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D007668:Kidney / Q000473:pathology; D007672:Kidney Cortex / Q000187:drug effects / Q000378:metabolism; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D009393:Nephritis / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D010713:Phosphatidylcholines / Q000378:metabolism; D011239:Prednisolone / Q000627:therapeutic use; D011507:Proteinuria / Q000517:prevention & control; D011719:Pyrazines / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013482:Superoxide Dismutase / Q000378:metabolism; D013481:Superoxides / Q000378:metabolism
D000975:Antioxidants; D016166:Free Radical Scavengers; D010713:Phosphatidylcholines; D011719:Pyrazines; C057590:phosphatidylcholine hydroperoxide; D013481:Superoxides; C067708:OPC 15161; D008315:Malondialdehyde; D004176:Dipyridamole; D011239:Prednisolone; D013482:Superoxide Dismutase